Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise | December 22, 2020 |

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. ...
Streetwise Reports | April 2, 2020 |

How This Company is Tapping Into the Growing Cannabis Vaping Market

(Click image to watch video) Cannabis vape products, in particular, have been gaining traction as legalization of the recreational drug becomes more widespread in certain U.S. states. Case in point, it is estimated that in states like California, Colorado, Ne...
Jocelyn Aspa | May 7, 2021 |

Meet THE Pioneers and Industry Leaders in Digital Asset Mining

Bitcoin is back and still trading in the 40-thousand dollar range. Hut 8 Mining Corp. (HUT) ( TSX.HUT , NASDAQ: HUT , OTCMKTS: HUTWF , Forum ) is a global industry leader in digital asset mining and one of the crypto space’s true pioneers. The company&C...
Dave Jackson | July 30, 2021 |

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. In a March 18 research note, H.C. Wainwright & Co. analyst Andrew Fein purported that Constellation Pharmaceuticals Inc.'s (CNST:NASDAQ) "strong and balanced pi...
Streetwise Reports | March 25, 2019 |

Coverage Initiated on Biotech Whose Therapies 'Can Compete with CAR-Ts'

The reasons for the Buy rating on the U.K. firm are delineated in a ROTH Capital Partners report. In a May 30 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on Adaptimmune Therapeutics Plc (ADAP:NASDAQ) with a...
Streetwise Reports | June 10, 2019 |

RingCentral's Partnership with Avaya Sends Both Firms Shares Up 25%

Shares of RingCentral and Avaya Holdings are soaring today after the announcement that RingCentral will become Avaya's exclusive Unified Communications as a Service (UCaaS) solutions provider. Yesterday afternoon after the markets closed, RingCentral Inc. (RNG:NYSE) ...
Streetwise Reports | October 8, 2019 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. Yesterday afternoon, Dermira Inc. (DERM:NASDAQ) , a biopharmaceu...
Streetwise Reports | October 21, 2019 |
1 2 3 4
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested